Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study Meeting Abstract


Authors: Reckamp, K. L.; Akerley, W.; Calvo, E.; Clarke, J.; Edelman, M. J.; He, K.; Moreno, V.; Neal, J. W.; Owonikoko, T. K.; Patel, J. D.; Patel, S. P.; Riess, J. W.; Sacher, A. G.; Turcotte, S.; Villaruz, L. C.; Zauderer, M. G.; Farsaci, B.; Skoura, N.; Chisamore, M.; Johnson, M. L.
Abstract Title: Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study
Meeting Title: 44th ESMO Congress (ESMO 2019)
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 5
Meeting Dates: 2019 Sep 27-Oct 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-10-01
Start Page: mdz260.112
Language: English
ACCESSION: WOS:000491295504252
PROVIDER: wos
DOI: 10.1093/annonc/mdz260.112
Notes: Meeting Abstract: 1590TiP -- Appears on pages v657-v658 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Marjorie G Zauderer
    189 Zauderer